I was curious whether tirzepatide or retatrutide is the better GLP-1, so I evaluated them properly through: 3 variables: weight loss, muscle loss, side effects
Induction of labour versus expectant management for large-for-date fetuses: A randomised controlled trial
Oral ferroportin inhibitor vit-2763: first-in-human, phase 1 study in healthy volunteers
TA664 for liraglutide 3.0 mg) recommend considering GLP-1 agonists for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds), or a BMI of 30-34.9 kg/m with at least one weight-related comorbidity
B12 Injections for severe deficiency or those who can't absorb oral supplements